Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Joseph Tucker
Recent news which mentions Joseph Tucker
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
Tickers
ENVB
NEWS
Tags
ENVB
Joseph Tucker
Psychedelics earnings
From
Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
Tickers
ENVB
NEWS
Tags
Joseph Tucker
mental health
Psychedelics
From
Benzinga
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
October 15, 2024
Tickers
ENVB
NEWS
Tags
ENVB
Market News
Cannabis
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
ATAI Life Sciences
Benzinga
Psychedelics
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
Tickers
CCC
ENVB
NEWS
Tags
Benzinga
Psychedelics
Psychedelics Research
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Tickers
DMT
ENVB
NEWS
Tags
Market News
Cannabis
Joseph Tucker
From
Benzinga
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
July 11, 2024
Tickers
ENVB
Tags
ENVB
Joseph Tucker
Enveric
From
Benzinga
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
May 16, 2024
Tickers
ENVB
NEWS
Tags
EB/003
Cannabis
Market News
From
Benzinga
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
ENVB
Market News
Cannabis
From
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Tickers
ENVB
NEWS
Tags
Cannabis
Market News
cannabis breast cancer
From
Benzinga
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
August 21, 2023
Tickers
ENVB
Tags
premium
Penny Stocks
Psychedelics
From
Benzinga
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
July 24, 2023
Tickers
ENVB
Tags
Joseph Tucker
ENVB
Market News
From
Benzinga
Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety
July 17, 2023
Tickers
ENVB
Tags
News
premium
Psychedelics
From
Benzinga
Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
June 26, 2023
Tickers
ENVB
Tags
Joseph Tucker
ENVB
Markets
From
Benzinga
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
June 05, 2023
Tickers
ENVB
Tags
Why is it moving?
ENVB
Joseph Tucker
From
Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
May 24, 2023
Tickers
ENVB
Tags
Markets
Market News
Cannabis
From
Benzinga
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
May 22, 2023
Tickers
ENVB
Tags
ENVB
Markets
Market News
From
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Tickers
ENVB
Tags
Markets
Market News
Cannabis
From
Benzinga
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Tickers
ENVB
Tags
Cannabis
Market News
Markets
From
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Tickers
ENVB
PSYBF
TRYPF
Tags
Psychedelics
Tryp Therapeutics
PSYBF
From
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
Tickers
CBD
ENVB
Tags
osteoarthritis
CBD
News
From
Benzinga
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
Tickers
ENVB
TGODF
TLRY
Tags
Entrepreneurship
ENVB
appointments
From
Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
September 17, 2021
Tickers
ENVB
Tags
MagicMed
ENVB
Joseph Tucker
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.